The study on Influenza D and Canine Coronavirus HuPn-2018 underscores urgent needs for targeted surveillance and diagnostics ...
Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...
The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...
Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...
How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...
A team of researchers from the Ministry of Health in Kuwait has successfully demonstrated the destruction of SARS-CoV-2 virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results